Osaka, Japan

Motohide Sato

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Japan Tobacco Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motohide Sato. Retrieved from https://idiyas.com/inventor/motohide-sato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Motohide Sato: Innovator in Pharmaceutical Chemistry

Introduction

Motohide Sato is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinazoline derivatives. His research has the potential to impact various therapeutic applications.

Latest Patents

Motohide Sato holds a patent for "3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same." This patent includes compounds represented by the formula (I), which are designed to enhance pharmaceutical efficacy.

Career Highlights

Sato is associated with Japan Tobacco Inc., where he has been instrumental in advancing research initiatives. His work has led to the development of novel compounds that may offer new avenues for treatment in various medical conditions.

Collaborations

Throughout his career, Motohide Sato has collaborated with notable colleagues, including Takeo Katsushima and Hajime Kinoshita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Motohide Sato's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new therapeutic solutions. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…